Table 2. Weight variations in treatment groups during comparative efficacy study of OlPC in L. major infected BALB/c mice.

Day	Vehicle control	%1	fluconazole	%	miltefosine	%	OlPC	%	amphoB	%
Baseline	22.8±0.4		23.1±0.5		24.2±0.7		22.6±0.3		22.7±0.3
	n = 6		n = 6		n = 6		n = 6		n = 6
4	22.3±0.3	−2.2	22.4±0.3	−3.0	22.0±0.6	−9.3	21.5±0.5	−4.9	22.3±0.3	−1.8
	n = 6		n = 6		n = 6		n = 6		n = 6
10	21.2±0.3	−7.1	21.2±0.3	−8.2	20.6±0.2	−14.9	21.7±0.4	−4.0	21.1±0.5	−7.1
	n = 6		n = 6		n = 6		n = 6		n = 6
13	21.1±0.4	−7.5	20.8±0.4	−10.0	19.3±0.8	−20.6	21.0±0.8	−6.9	23.1±0.2	+2.0
	n = 6		n = 6		n = 4		n = 5		n = 6
27	21.3±0.5	−6.4	20.7±0.4	−10.4	22.0±1.0	−9.1	21.6±0.7	−4.5	23.4±0.4	+2.9
	n = 6		n = 5		n = 3		n = 3		n = 6
34	20.8±0.7	−8.9	20.0±0.4	−13.4	21.6±0.1	−11.0	23.7±0.6	+5.0	23.0±0.4	+1.5
	n = 52		n = 5		n = 3		n = 3		n = 6

¹% compared to baseline weight;

²No weight available for mouse #584 on Day 34.